ArticlePloS one2017

Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.

Yueh-Lun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.